All posts by admin

18Mar/14

Biosimilar monoclonal antibodies emerge from the pipeline on both sides of the … – Lexology (registration)

Biosimilar monoclonal antibodies emerge from the pipeline on both sides of the …
Lexology (registration)
The European Medicines Agency (“EMEA”) made its biosimilar monoclonal antibody guidelines effective in December 20121. Less than a year later, in September 2013, it approved Europe’s first biosimilar antibody. The drug is Inflectra which is a …

18Mar/14

Asia-Pacific non-small cell lung cancer therapeutics market to reach $2.9 … – Times of India


The Pharma Letter

Asia-Pacific non-small cell lung cancer therapeutics market to reach $2.9 …
Times of India
MUMBAI: The non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region — Australia, China, India and Japan is expected to increase moderately over the coming years, climbing from $1.8 billion in 2012 to $2.9 billion …
MarketReserachReports.com: Non-Small Cell Lung Cancer Therapeutics Market …MENAFN.COM

all 5 news articles »